This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation May 5, 2010
FDA approves $93K prostate cancer vaccine
USA TODAY    Share   Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration on April 29 approved the first vaccine to treat prostate cancer -- or any cancer -- the culmination of decades of research into harnessing the immune system to fight tumors. The $93,000 vaccine, Provenge, doesn't prevent cancer, unlike the polio shot or recently approved vaccines that block infection with viruses that cause most cervical tumors. Provenge also doesn't cure cancer. More

Injection of melanin nanoparticles could make human body radiation-resistant
Popular Science    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One of the major downsides of radiation therapy, which commonly is used to shrink cancerous tumors, is its harmful effect on normal cells. Now, thanks to research done by scientists at the Albert Einstein College of Medicine of Yeshiva University, doctors someday may use melanin-covered nanoparticles to administer higher doses of radiation to cancerous cells without compromising the healthy ones. More

Study: Immune cells predict success of head, neck cancer treatment
University of Michigan Health System    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Levels of a key type of immune cell are higher in head and neck cancer patients whose tumors are linked to the human papillomavirus, according to researchers at the University of Michigan Comprehensive Cancer Center. The finding suggests a way to predict which tumors are most likely to respond to chemotherapy and radiation and allow doctors to choose the best treatment option up front. More

Platinum Medical Imaging: Excellence in Systems, Service, Parts, and Support

Platinum Medical Imaging specializes in working with Cancer Centers to provide factory certified, fully refurbished CT Scanners dedicated for Oncology. Visit us at

Enzyme found to be predictive marker of survival in head, neck cancer    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most treatment for advanced head and neck cancer requires chemotherapy with a drug called cisplatin. A substantial number of patients do not respond well to this therapy, but oncologists are unable to prescribe alternative agents because they don't know which patients will respond to platinum therapy. However, new research from Fox Chase Cancer Center suggests that levels of ERCC1 offer a predictive marker of survival in squamous carcinoma of the head and neck. More

How IBM's world community grid is helping cure AIDS, cancer, world hunger
Fast Company    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For the past four years, Lauren Moran has devoted herself to groundbreaking cancer research, chronicling the fickle interaction between molecules and proteins. Despite having a full-time job -- "stat geek" on the New York Yankees' media relations staff -- Moran screens drug candidates daily. And continuously. She conducts experiments while talking on the phone to her parents, attending games at Yankee Stadium and watching episodes of "The Office" in her Bronx apartment. Even in the dead of night. More

Gaps in insurance policies make oral drugs too pricey for some cancer patients
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When Jere Carpentier learned last year that she had advanced colon cancer -- her third malignancy in a dozen years -- she worried about spending hours in a clinic tethered to an intravenous line, enduring punishing chemotherapy that would make her hair fall out. Her veins ruined by earlier treatments, Carpentier was elated when her oncologist said this time she could avoid needles and take a pill at home that specifically would target the cancer cells and spare her hair. More

Go Beyond Billing

RadMax Radiation Oncology Billing Service combines advanced technology, total value, and dedicated customer service to meet all your AR management needs.

Oral, throat cancers can be silent killers
Dentistry IQ    Share    Share on FacebookTwitterShare on LinkedinE-mail article
This year, more than 35,000 people in the United States will receive a diagnose of oral or pharyngeal cancer, and according to the Oral Cancer Foundation nearly half of will die within five years. In recognition of Oral, Head and Neck Cancer Awareness Week, which took place in mid-April, Dr. Steven Sobol, an otolaryngologist working out of the ENTA practice on the Decatur Memorial Hospital campus, addressed the topic. More

Radiation Oncology Consulting

Churchill Consulting, Inc., providing expert products and services since 1992. Premier product is DIRECTREES® (coding help application). Services include comprehensive chart audits, coding seminars, compliance programs, and QA Programs

Candy-like tobacco products: Poisoning is not only risk
U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Tobacco products that look and taste like candy, and have poisoned thousands of children who mistake them for sweet treats, are just the latest in a long line of tobacco goods that appeal to children. The threat they pose to children is not only poisoning but an increased risk of addiction. Smokeless tobacco products poisoned 1,768 children younger than age 6 between 2006 and 2008, researchers at the Harvard School of Public Health recently reported in Pediatrics. More

Waxman calls for baseball ban on smokeless tobacco
Bloomberg BusinessWeek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Major League Baseball should ban players from using smokeless tobacco in dugouts and on the field because of its health risks and influence on children, said Rep. Henry Waxman, chairman of the House Committee on Energy and Commerce. "Millions of young fans are exposed on a daily basis to the use of smokeless tobacco by their heroes," Waxman, a California Democrat, said recently at a hearing in Washington. More

Say "goodbye" to good enough.

Discover 10 ways TomoTherapy technology is being used to advance cancer care around the world.

RadOnc Weekly
James DeBois, Director of Advertising Sales, 469.420.2618   Download media kit
Patrick McCoy, Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 28, 2010
April 21, 2010
April 14, 2010
April 7, 2010

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063